Polymer conjugates: nanosized medicines for treating cancer.
about
The effect of surface nanometre-scale morphology on protein adsorptionMolecular Dynamic Studies of the Complex Polyethylenimine and Glucose OxidaseCombinatorial peptide libraries: mining for cell-binding peptides.Potential applications and human biosafety of nanomaterials used in nanomedicinePeptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.Efficacy of polyMPC-DOX prodrugs in 4T1 tumor-bearing miceA health services research agenda for cellular, molecular and genomic technologies in cancer care.pH-responsive NIR enhanced drug release from gold nanocages possesses high potency against cancer cells.Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells.Polymer-Based TherapeuticsA reduction-sensitive carrier system using mesoporous silica nanospheres with biodegradable polyester as caps.Development of a novel endosomolytic diblock copolymer for siRNA deliveryPEG-like nanoprobes: multimodal, pharmacokinetically and optically tunable nanomaterials.Applications of orthogonal "click" chemistries in the synthesis of functional soft materials.Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis.Mechanism study of peptide GMBP1 and its receptor GRP78 in modulating gastric cancer MDR by iTRAQ-based proteomic analysis.Noninvasive detection of passively targeted poly(ethylene glycol) nanocarriers in tumors.Anticancer efficacy of perillyl alcohol-bearing PLGA microparticlesRAFT-synthesized graft copolymers that enhance pH-dependent membrane destabilization and protein circulation timesPentafluorophenyl Ester-based Polymersomes as Nanosized Drug-Delivery Vehicles.A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation.Comparative biodistribution of PAMAM dendrimers and HPMA copolymers in ovarian-tumor-bearing miceLinear cyclodextrin-containing polymers and their use as delivery agents.Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors.Nanotechnology for targeted cancer therapy.Anticancer carrier-linked prodrugs in clinical trials.Tumor-targeted induction of oxystress for cancer therapy.Polymer-drug conjugates as modulators of cellular apoptosis.Nanovehicular intracellular delivery systems.Design, synthesis and applications of hyaluronic acid-paclitaxel bioconjugates.Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives.Slow self-activation enhances the potency of viridin prodrugsN-(2-hydroxypropyl)methacrylamide-amphotericin B (HPMA-AmB) copolymer conjugates as antileishmanial agents.Chemotherapy drug delivery from calcium phosphate nanoparticles.Novel technologies for antiangiogenic drug delivery in the brain.LHRH-targeted nanogels as a delivery system for cisplatin to ovarian cancer.Cell penetrating elastin-like polypeptides for therapeutic peptide delivery.Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery.Polymer-drug conjugates for novel molecular targets.Nanomaterials: applications in cancer imaging and therapy.
P2860
Q21136246-FFEC97D6-A7FF-407B-B8DB-17DE30861224Q28818127-71F024C8-B7BE-4741-8272-98717C9465E1Q31144876-A15AABBC-2B30-4F11-926F-7CA29D85F159Q32944368-F17E2033-3367-4DE0-A143-5C8BA0B3DD83Q33520512-BE7F7039-57C6-47C9-A62B-6BDC905C6B14Q33598779-9DE24404-E638-419B-A60A-719A57B577BAQ33749983-B0295885-4DA8-4F98-900B-95E3007FA943Q34317633-E6A68E26-42D7-4E40-9307-59CBCF81F8A2Q34721854-32EB1B85-7D1E-46B1-AB5B-C05E9E5F6F6FQ34781736-9F39B022-A366-4586-A70B-B5B676F8F064Q34861280-7F7E0239-C081-4F6F-A7D9-FD63CD746514Q35031634-7B662B77-AD5C-471B-B1A5-0ABA79B50684Q35159784-9CC5096D-109E-4913-9028-50EB40A22954Q35190403-04B57009-99BB-40C3-8479-4DD56A6A21C3Q35201491-081F812E-A74F-4F7C-AE8D-56C9615ABC10Q35604249-727D764E-544C-4D99-ACEB-C461155D575CQ35671286-34BA4994-DB82-4F91-8E63-F54620C2FDA9Q35679851-965C3A4E-A805-4450-A2A5-33AF59CF59D9Q35739852-6961D7DD-E129-4E04-897F-876598B0A5C6Q35812791-4A04DA66-5DB3-4D07-BAA5-11990752CDAFQ35939307-339AB822-FBCD-4796-A5D7-5659E7AED805Q36334384-0D16DC0B-3493-4079-BC5B-BDDE20E928B2Q36583740-DFA5FD1E-EEB1-48EF-96A6-456FE0541D12Q36651667-BBA4F391-79F4-4473-B312-53141857B60DQ36842770-1BFDEFD8-74AA-4715-B644-1DC1F21EADD8Q36861603-71639F5C-F62F-4296-BFA2-482254C5250BQ36900213-F1A540D7-3CE7-4794-9D73-9D573BA4DC4CQ36956674-EBACA0EA-5064-4976-9065-B676E6B1BB19Q37058812-E062D16A-FFA2-426E-9DF8-52892EC75C59Q37096500-71471CEE-9F27-4741-8F37-4C32AE9DB23FQ37130501-26366A41-194C-4629-ABAB-2EF6632065B9Q37145614-9C778CBD-29BD-488B-ACA0-C90C7073F470Q37159459-768FEF10-3384-4F99-AC62-352350BAD026Q37178507-B1117D98-EDF3-432B-AFBA-76AF96BD6152Q37186246-54963643-27FB-4574-943F-CA6700B6B807Q37259176-71058D85-4640-4BCD-AE19-1A6A349C6C34Q37755594-73EA7693-3751-46F4-B4E6-CA39063D0C81Q37775972-6E2390E2-D8BE-42AE-B56F-99E109A5E059Q37782076-0C0F2A31-1590-433E-BA7C-0082FFFFF79EQ37857064-E0AB4946-450A-4CBA-BC44-1BEB51816038
P2860
Polymer conjugates: nanosized medicines for treating cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Polymer conjugates: nanosized medicines for treating cancer.
@ast
Polymer conjugates: nanosized medicines for treating cancer.
@en
Polymer conjugates: nanosized medicines for treating cancer.
@nl
type
label
Polymer conjugates: nanosized medicines for treating cancer.
@ast
Polymer conjugates: nanosized medicines for treating cancer.
@en
Polymer conjugates: nanosized medicines for treating cancer.
@nl
prefLabel
Polymer conjugates: nanosized medicines for treating cancer.
@ast
Polymer conjugates: nanosized medicines for treating cancer.
@en
Polymer conjugates: nanosized medicines for treating cancer.
@nl
P1476
Polymer conjugates: nanosized medicines for treating cancer.
@en
P2093
María J Vicent
Ruth Duncan
P356
10.1016/J.TIBTECH.2005.11.006
P577
2005-11-22T00:00:00Z